In Vitro Drug Combination Screening Services
Drug Combination Services
In Vitro Drug Combination Screening Services Overview
Drug combination therapy has evolved into the standard treatment for complex diseases, such as AIDS and cancer. In comparison to single drug therapy, drug combination therapy offers several advantages:
- Improved Therapeutic Effect: Combining drugs can enhance the overall treatment efficacy.
- Reduced Dosing: Drug combinations can allow for the reduction of individual drug doses while achieving or maintaining the same level of efficacy, thus minimizing the risk of toxicity.
- Resistance Management: Combining drugs can help overcome and slow down the development of drug resistance, a common challenge in disease treatment.
- Selective Synergism: Drug combinations can be tailored to exploit synergistic interactions between specific medications.
Kyinno utilizes a standardized High-throughput screening (HTS) approach to analyze the phenotypic effects of thousands of drug combinations in preclinical model systems. In recent years, cutting-edge machine learning models have been employed to predict the sensitivity and synergy of drug combinations, alongside the development of more comprehensive reference models for measuring the combination index.
Our platform incorporates reference models such as:
✔ Bliss Independence
✔ Loewe Additivity
✔ Zero Interaction Potency (ZIP)
✔ Highest Single Agent (HSA) Model
Our In Vitro Drug Combination Screening Workflow
- Study Design & Consultation – Defining research goals and selecting appropriate in vitro models.
- High-Throughput Screening (HTS) – Systematic evaluation of drug interactions across multiple conditions.
- Data Collection & Analysis – Measuring drug synergy and antagonism through validated reference models.
- Machine Learning Integration – Using predictive AI models to assess drug response and sensitivity.
- Comprehensive Reporting – Delivering a detailed study report with data interpretation and recommendations.
Advantages of Our In Vitro Screening Services
KYinno’s in vitro drug combination screening platform provides scientifically validated insights that support drug development. Key advantages include:
✔ Identification of Synergistic Drug Pairs – Detecting interactions that enhance therapeutic outcomes.
✔ Comprehensive Mechanistic Insights – Understanding drug-drug interactions at a molecular level.
✔ Scalability & High-Throughput Efficiency – Rapidly evaluating large datasets with automated systems.
✔ Predictive Modeling for Drug Response – Utilizing AI-powered tools to refine screening accuracy.
✔ Standardized Data Analysis – Ensuring reproducibility and comparability across experiments.
Our platform bridges preclinical research and translational medicine, providing researchers with high-quality, actionable data.
Customized In Vitro Drug Screening Solutions
Recognizing that each research project has unique objectives, we offer tailored solutions:
- Cell Model Selection – Working with cancer cells, primary cells, and patient-derived models.
- Flexible Dosing Strategies – Testing multiple concentration gradients to optimize efficacy.
- AI-Powered Predictive Analytics – Machine learning models for forecasting drug responses.
- Custom Mechanistic Studies – Investigating pathway interactions and biomarker expression.
- High-Resolution Imaging & Assay Integration – Supporting diverse readout techniques.
We collaborate with researchers to design customized study protocols that align with specific therapeutic goals.
Expert Support Throughout Your Project
Our team provides end-to-end scientific support to ensure successful study execution:
📌 Pre-Study Consultation – Assistance in designing protocols and selecting models.
📌 Data Monitoring & Quality Control – Continuous assessment to maintain result integrity.
📌 Troubleshooting & Optimization – Addressing experimental challenges for reliable outcomes.
📌 Post-Study Interpretation – Comprehensive discussions to translate findings into research applications.
With extensive expertise in in vitro combination studies, we help researchers accelerate data-driven decision-making.
Start Your In Vitro Drug Combination Research with KYinno
Advance your in vitro drug combination research with KYinno in three simple steps:
1️⃣ Schedule a consultation – Discuss your research needs and objectives.
2️⃣ Receive a tailored study proposal – Get a customized screening plan with methodology and pricing.
3️⃣ Obtain high-quality, data-driven insights – Conduct experiments with rigorous quality control and receive a comprehensive report.
Contact us today to explore how our in vitro screening services can support your research.
Scientific Resources & Publications
In a recent study, we investigated the synergistic effects of EGFR and MET inhibitors in overcoming drug resistance in lung cancer models. Using H1975-HGF cells, engineered to overexpress HGF and activate MET signaling, we tested AZD9291 (EGFR inhibitor) and AZD6094 (MET inhibitor).
Individually, neither drug effectively inhibited tumor growth; however, their combined treatment demonstrated a significant synergistic effect, leading to reduced tumor proliferation.
These findings underscore the potential of combination therapy in addressing resistance mechanisms, offering valuable insights for targeted cancer treatment strategies.
All Drug Combination Services
In vivo combination studies offer insight into drug interactions facilitating profound insight into therapeutic dynamics, paving the way for enhanced medical research, optimizing patient care, and driving informed decision-making processes.
In vitro combination studies provide an in-depth analysis of cellular interactions. They illuminate drug synergy or antagonism, serving as an essential tool for crafting enhanced therapeutic strategies and optimized drug formulations.
Our AI-prediction platform excels in predicting drug responses, interactions, and potential outcomes. Utilizing cutting-edge technology, we accelerate drug development, ensuring a more efficient and effective approach to the development of therapeutic strategies.